DEA's Schedule I Ban on Promising Opioid Treatment Could Halt Research

The DEA has placed a drug, regarded by some opioid users as a miracle treatment, under Schedule I classification. Researchers warn that this ban may prevent further studies into the drug's potential as an opioid treatment. This decision comes amid ongoing efforts to address opioid addiction and pain management.

Originally published by arstechnica